Access free, up-to-date clinical references for comprehensive information on assessing multiple sclerosis at Healio. Our content provides valuable insights for physicians.

Clinical Features of Multiple Sclerosis. Perez CA, Smith A, Nelson F. In: Multiple Sclerosis: A Practical Manual for Hospital and Outpatient Care. Cambridge University Press; 2021:21-36.

FSD Pharma Inc. (NASDAQ: HUGE) has dosed the first subjects in its first clinical trial assessing the New Chemical Entity (NCE) Lucid-21-302, or Lucid-MS, targetting multiple sclerosis.

Medical experts discuss the failure of evobrutinib to meet its primary endpoint in phase 3 trials, review the primary outcomes of the phase 2B study of tolebrutinib in relapsing multiple sclerosis ...

A total of 234 COVID-19 cases were identified among multiple sclerosis patients, of which 13.2% were hospitalized and 2.1% (5 patients) died due to the infection.

The  (MSAA) is pleased to provide vital services and resources to individuals affected by MS, their families, and care ...

A multiple sclerosis expert shares how the understanding and treatment of the disease have evolved over the ... Bruce A. Cohen, MD, Davee Department of Neurology and Clinical Neurosciences, ...

Medical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and ...

But when this twitching is from multiple sclerosis (MS), this facial twitching may spread. It might go down your cheek to your mouth or jawline. And it happens more often.

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib ...

A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer anti-inflammatory benefits in multiple sclerosis.